Recurrent endometrial polyps in postmenopausal breast cancer patients on tamoxifen
Authors:
- Ron TepperRTRon Tepper
- Ami FishmanAFAmi Fishman
- Jeremiah ShapiraJSJeremiah Shapira
- Ilan CohenICIlan Cohen
- 1 August 2003
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 90 (2) , 382-386
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patientsBreast Cancer Research and Treatment, 1999
- Value of Sonohysterography in Asymptomatic Postmenopausal Tamoxifen-Treated PatientsGynecologic Oncology, 1997
- Time-Dependent Effect of Tamoxifen Therapy on Endometrial Pathology in Asymptomatic Postmenopausal Breast Cancer PatientsInternational Journal of Gynecological Pathology, 1996
- Continuous Tamoxifen Treatment in Asymptomatic, Postmenopausal Breast Cancer Patients Does Not Cause Aggravation of Endometrial PathologiesGynecologic Oncology, 1994
- Pathology of endometrium treated with tamoxifen.Journal of Clinical Pathology, 1994
- Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trialThe Lancet, 1994
- Endometrial Changes with Tamoxifen: Comparison between Tamoxifen-Treated and Nontreated Asymptomatic, Postmenopausal Breast Cancer PatientsGynecologic Oncology, 1994
- Endometrial lesions in patients undergoing tamoxifen therapyInternational Journal of Gynecology & Obstetrics, 1991
- Endometrial Polyps in Postmenopausal Patients Receiving TamoxifenInternational Journal of Gynecological Pathology, 1989
- TAMOXIFEN AND THE UTERUS AND ENDOMETRIUMThe Lancet, 1989